January, 26 2012, 08:49am EDT
For Immediate Release
Contact:
ASA Chief Counsel Joe Elford 415-573-7842 or ASA Media Liaison Kris Hermes 510-681-6361
Â
Patient Advocates File Appeal Brief in Federal Case to Reclassify Medical Marijuana
Lawsuit in the D.C. Circuit challenges DEA denial to reschedule marijuana for medical use
WASHINGTON
The country's leading medical marijuana advocacy group, Americans for Safe Access (ASA), filed an appeal brief today in the D.C. Circuit to compel the federal government to reclassify marijuana for medical use. In July 2011, the federal Drug Enforcement Administration (DEA) denied a petition filed in 2002 by the Coalition for Rescheduling Cannabis (CRC), which was denied only after the coalition sued the government for unreasonable delay. The ASA brief filed today is an appeal of the CRC rescheduling denial.
"By ignoring the wealth of scientific evidence that clearly shows the therapeutic value of marijuana, the Obama Administration is playing politics at the expense of sick and dying Americans," said ASA Chief Counsel Joe Elford, who filed the appeal today. "For the first time in more than 15 years we will be able to present evidence in court to challenge the government's flawed position on medical marijuana." Although two other rescheduling petitions have been filed since the establishment of the Controlled Substances Act in 1970, the merits of medical efficacy was reviewed only once by the courts in 1994.
The ASA appeal brief asserts that the federal government acted arbitrarily and capriciously in its efforts to deny marijuana to millions of patients throughout the United States. ASA argues in the brief that the DEA has no "license to apply different criteria to marijuana than to other drugs, ignore critical scientific data, misrepresent social science research, or rely upon unsubstantiated assumptions, as the DEA has done in this case." ASA is urging the court to "require the DEA to analyze the scientific data evenhandedly," and order "a hearing and findings based on the scientific record."
Patient advocates argue that by failing to reclassify marijuana, the federal government has stifled meaningful research into a wide array of therapeutic uses, such as pain relief, appetite stimulation, nausea suppression, and spasticity control among many other benefits. In 1988, the government ignored the ruling of its own Administrative Law Judge Francis Young who said that, "Marijuana, in its natural form, is one of the safest therapeutically active substances known to man."
Since the CRC petition was filed in 2002, an even greater number of studies have been published that show the medical benefits of marijuana for illnesses such as neuropathic pain, multiple sclerosis, and Alzheimer's. Recent studies even show that marijuana may inhibit the growth of cancer cells. Last year, the National Cancer Institute, a division of the federal Department of Health and Human Services, added cannabis to its list of Complementary Alternative Medicines, pointing out that it's been therapeutically used for millennia. The ASA appeal asserts that scientific evidence that was studied or discovered after 2002 is still relevant and must be considered.
Attorneys David Holland and Michael Kennedy filed the original petition in 2002 on behalf the Coalition for Rescheduling Cannabis, which included several individual patients and groups, such as ASA and Patients Out of Time.
AFI: Several patient-petitioners are available for interviews:
William Britt -- 562-818-0420
Mr. Britt is a 52-year-old resident of Long Beach, California, who developed polio as a child, which caused him to have scoliosis, a fused left ankle, shortened left leg, and bone degeneration in his left hip. Mr. Britt also suffers from epilepsy, depression and insomnia, and uses marijuana to treat chronic pain in his leg, back, and hip. Marijuana has reduced Mr. Britt's seizures and depression, and helps him sleep. Although Mr. Britt has taken prescription medication such as Marinol, Robaxin, Soma, and Xanax, none has proven as effective as marijuana.
Michael Krawitz -- 540-365-2141
Mr. Krawitz is a 49-year-old resident of Elliston, Virginia, who suffered an automobile accident in 1984 while serving in the United States Air Force. Mr. Krawitz has been rated by the United States Department of Veterans Affairs (VA) as being totally and permanently disabled. Mr. Krawitz uses marijuana to treat chronic pain and trauma associated with his accident. He also use marijuana to treat central serous retinopathy. However, because of Mr. Krawitz's medical marijuana use, he has been denied pain treatment by the VA.
Steph Sherer -- 510-872-7822
Ms. Sherer is a resident of Washington, D.C. and the founder and Executive Director of Americans for Safe Access (ASA). In April of 2000, Ms. Sherer suffered a physical attack that has caused her to suffer from a condition known as torticollis, which causes her to experience inflammation, muscle spasms, pain throughout her body, and decreased mobility in her neck. Because of pain medication she was prescribed, including Soma, Robaxin and Ibuprofin, Ms. Sherer suffered kidney damage. After her doctor recommended medical marijuana, Ms. Sherer successfully reduced her inflammation, muscle spasms, and pain. This prompted Ms. Sherer to found ASA in April of 2002 to share what she learned about the medical benefits of marijuana with others. Since then, ASA has grown to more than thirty-five thousand members, including many seriously ill persons who would have benefited from the use of marijuana for medical purposes, but who were deterred from doing so, in part, by the government's statements that marijuana "has no currently accepted medical use in treatment in the United States."
Further information:
ASA appeal brief filed today: https://AmericansForSafeAccess.org/downloads/CRC_Appeal.pdf
DEA answer to CRC petition: https://AmericansForSafeAccess.org/downloads/CRC_Petition_DEA_Answer.pdf
CRC rescheduling petition: https://www.drugscience.org/PDF/Petition_Final_2002.pdf
Americans for Safe Access is the nation's largest organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research.
LATEST NEWS
FTC Probing 'Blockbuster' Exxon-Pioneer Merger
"The FTC is right to investigate Exxon's acquisition of Pioneer, which could raise prices at the pump and is aimed at keeping the U.S. reliant on fossil fuels," said one campaigner.
Dec 05, 2023
Amid outrage from climate campaigners and senators, the U.S. Federal Trade Commission is investigating fossil fuel giant ExxonMobil's proposed takeover of Pioneer Natural Resources, a regulatory filing revealed Tuesday.
Pioneer disclosed the FTC's request for more information about the pending merger, which Exxon announced in October.
U.S. Senate Majority Leader Chuck Schumer (D-N.Y.) said in a statement Tuesday: "Last month, I and 22 other senators urged the FTC to investigate Exxon's $60 billion proposed blockbuster merger with Pioneer. And today—they heeded my warning."
"Americans care a great deal about gas prices," Schumer stressed, "and if this merger were to go through it would most certainly raise gas prices for families across the country."
"This merger has all the hallmarks of harmful, anticompetitive effects. The FTC is right to investigate this merger to see if it would lead to higher gas prices or less competition," he added. "I look forward to following this investigation closely, and will encourage the FTC to block the deal if they find any antitrust laws are being violated."
Alex Witt of Climate Power, an advocacy group founded by the Center for American Progress (CAP) Action Fund, League of Conservation Voters, and Sierra Club, also welcomed the FTC's inquiry in comments to The Associated Press.
"Exxon publicly promised to reduce emissions, yet subsequently spent $60 billion acquiring another fossil fuel company—doubling down on their commitment to oil and gas and putting profits over people," Witt said. "The FTC is right to investigate Exxon's acquisition of Pioneer, which could raise prices at the pump and is aimed at keeping the U.S. reliant on fossil fuels."
A CAP report highlighted Tuesday that in hopes of continuing to profit off of the destruction of the planet, the fossil fuel industry is "undermining democratic functions to stem the tide of climate action" around the world.
That report and the heightened scrutiny of the possible merger come during the United Nations Climate Change Conference (COP28), where attendees are considering scientists' warnings that fossil fuels must be rapidly phased out to prevent more devastating global heating.
"This deal shows that Exxon is doubling down on fossil fuels and has no intention of moving towards clean energy," Jamie Henn, director of Fossil Free Media argued earlier this year. "Even after the hottest summer on record, Exxon is hellbent on driving the thermostat even higher."
Keep ReadingShow Less
Big Oil Stifling Democracy to Keep Burning Fossil Fuels
"The multinational $4 trillion fossil fuel industry has not only corrupted citizens' understanding of the climate crisis but also contributed to the erosion of democracy around the world."
Dec 05, 2023
As more people around the world demand an end to the fossil fuel era in the face of a worsening planetary emergency, Big Oil is "undermining democratic functions to stem the tide of climate action," a report published Tuesday revealed.
"Through a wide array of tactics, the multinational $4 trillion fossil fuel industry has not only corrupted citizens' understanding of the climate crisis but also contributed to the erosion of democracy around the world," the Center for American Progress (CAP) said in a new analysis.
CAP's Chris Martinez, Laura Kilbury, and Joel Martinez examined "what these tactics look like in practice and how they work against democratic systems to stifle climate action."
According to the authors, the three main democracy-destroying tactics are:
- Polluting democratic societies' information ecosystems with deception and false climate solutions;
- Using massive financial and lobbying influence over policymakers to defeat climate action and serve industry interests; and
- Directly undermining democratic rights and freedoms.
The fossil fuel industry is "stifling democratic rights through lawsuits, anti-protest laws, and voter suppression," the report states. Meanwhile, Big Oil greenwashes its harmful practices through direct advertising and via lobby groups like the American Petroleum Institute, which "regularly publicizes its member companies' investments in renewable energy and carbon reduction technologies."
"On closer inspection, however, industry's declared efforts to fight climate change fall woefully short, with oil and gas companies often devoting more attention to creating the appearance of working on climate solutions than actually developing them," the analysis contends.
Big Oil also uses the tactic of "astroturfing," or creating the appearance of grassroots support for policies and practices that are beneficial to the industry but harm the climate by perpetuating the fossil fuel era.
"The oil and gas industry's strategy is clear: Manipulate the levers of power to obstruct any climate policies that may reduce the world's reliance on fossil fuels," Martinez, CAP's associate director for domestic climate, said in a statement. "If left unchecked, these tactics stifle democratic rights, making governments more responsive to corporations than their own citizens."
The CAP analysis comes as a record 2,456 fossil fuel lobbyists flood the floors of the United Nations Climate Change Conference, or COP28, in Dubai, peddling influence and false climate solutions like so-called "abated" emissions, biofuels, and hydrogen.
"In the case of the [United Arab Emirates'] COP28 presidency, the industry capture of these spaces is complete, with a state-backed fossil fuel company threatening to interfere with multilateral climate progress at the highest and most consequential level," the report states, referring to summit president Sultan Ahmed Al Jaber, who is also the CEO of the UAE's national oil firm—and who has reportedly been using the run-up to the conference to pursue new fossil fuel deals.
"As warning lights of democratic backsliding strobe across the world and endanger critical efforts to address the climate crisis," the analysis adds, "the twin threat of the fossil fuel industry's attacks on climate action and the democratic functions necessary to take that action must not be ignored."
Keep ReadingShow Less
13 Dems Oppose Resolution Conflating Anti-Zionism and Antisemitism
"This extreme and cynical Republican resolution does nothing to combat antisemitism," said Rep. Ilhan Omar, stressing the importance of "legitimate criticism" of the Israeli government and its war on Gaza.
Dec 05, 2023
As Israel continued to wage what critics are calling a genocidal war on the Gaza Strip, just 13 U.S. House Democrats and one Republican on Tuesday voted against a GOP resolution that conflates anti-Zionism and antisemitism.
House Resolution 894 passed with support from 95 Democrats and 216 Republicans, including its sponsors, Reps. David Kustoff (Tenn.) and Max Miller (Ohio), who are both Jewish. Almost as many Democrats—92—voted present.
The resolution, which embraces the International Holocaust Remembrance Alliance's controversial working definition of antisemitism, was widely condemned by progressive and Jewish groups this week ahead of the vote.
Republican Congressman Thomas Massie (Ky.) joined the 13 Democrats who opposed H.Res. 894: Reps. Jamaal Bowman (N.Y.), Cori Bush (Mo.), Gerry Connolly (Va.), Jesús "Chuy" GarcÃa (Ill.), Raúl Grijalva (Ariz.), Pramila Jayapal (Wash.), Summer Lee (Pa.), Alexandria Ocasio-Cortez (N.Y.), Ilhan Omar (Minn.), Ayanna Pressley (Mass.), Delia Ramirez (Ill.), Rashida Tlaib (Mich.), and Bonnie Watson Coleman (N.J.).
"This extreme and cynical Republican resolution does nothing to combat antisemitism, relies on a definition that conflates criticism of the Israeli government with antisemitism, paints critics of the Israeli government as antisemites, and falsely states that anti-Zionism is antisemitism," Omar said in a statement about her vote. "We must stand against any attempt to define legitimate criticism of this war and the government perpetrating it as antisemitism."
According to The Hill, Bowman said after the vote that while he "strongly condemn[s] antisemitism and hate in all of its forms," he voted against H.Res. 894 because "it fuels division and violence, conflates criticism of the Israeli government with antisemitism, and ignores one of the greatest threats to the Jewish community, white nationalism."
Bowman and Omar are among the House progressives facing serious primary challenges for the next cycle, in part because of their criticism of the Israeli government and its war on Gaza that has killed nearly 16,000 Palestinians in under two months.
They joined with Bush, Lee, Massie, Ocasio-Cortez, Ramirez, Tlaib, and Reps. André Carson (D-Ind.) and Al Green (D-Texas) in October to oppose a bipartisan resolution, which declared that the House unconditionally "stands with Israel as it defends itself against the barbaric war launched by Hamas and other terrorists," and did not mention Palestinian suffering.
Keep ReadingShow Less
Most Popular